US Patent Issued to INSULET on Sept. 30 for "User parameter dependent cost function for personalized reduction of hypoglycemia and/or hyperglycemia in a closed loop artificial pancreas system" (Massachusetts, Wisconsin Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,427,251, issued on Sept. 30, was assigned to INSULET Corp. (Acton, Mass.).

"User parameter dependent cost function for personalized reduction of hypoglycemia and/or hyperglycemia in a closed loop artificial pancreas system" was invented by Joon Bok Lee (Acton, Mass.), Yibin Zheng (Hartland, Wis.) and Jason O'Connor (Acton, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Exemplary embodiments described herein relate to a closed loop artificial pancreas system. The artificial pancreas system seeks to automatically and continuously control the blood glucose level of a user by emulating the endocrine functionality of a healthy pancreas. The artificial...